Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Clinical trial NCT03120949 · COMPLETED
Trial details
- NCT number
- NCT03120949
- Sponsor
- R-Pharm International, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-04
- Primary completion
- 2021-09-01
- Enrollment
- 2106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.